Synektik (FRA:A2P) Total Stockholders Equity: €50.7 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:A2P Synektik SA FRA:A2P
68 GF Score
Price €79.00
GF Value €67.97
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Synektik Total Stockholders Equity?

Synektik FRA:A2P +0.96% 68 Total Stockholders Equity is €50.7 Mil as of Jun. 2026. GuruFocus rates FRA:A2P with a GF Score™ of 68/100 and a GF Value™ of €67.97 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Synektik's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €50.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Synektik's Book Value per Share for the quarter that ended in Jun. 2026 was €5.94. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Synektik's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.19.

Synektik  (FRA:A2P) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Synektik's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(50.656-0)/8.529
=5.94

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Synektik's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(2.462 + 7.361) / 50.656
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synektik Total Stockholders Equity Related Terms

Synektik Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Synektik's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synektik Total Stockholders Equity Chart

Synektik Annual Data
Trend Dec14 Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.97 19.05 20.78 31.74 44.94

Synektik Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.22 52.87 61.10 37.52 50.66
FRA:A2P
68GF Score
Synektik SA FRA:A2P
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €50.7 Mil mean?
Synektik (FRA:A2P) has a Total Stockholders Equity of €50.7 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Synektik and its competitors.
Is Synektik's Total Stockholders Equity too high?
Synektik's current Total Stockholders Equity is €50.7 Mil. Overall, Synektik has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Total Stockholders Equity compare to ABT and SYK?
Synektik's Total Stockholders Equity of €50.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Synektik and its competitors. Synektik's current Total Stockholders Equity is €50.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (FRA:A2P) is currently considered Modestly Overvalued. The stock's GF Value™ is €67.97, compared to a current price of €79.00 — trading 16.2% above its estimated fair value. The current Total Stockholders Equity is €50.7 Mil. Synektik's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Synektik (FRA:A2P), the current Total Stockholders Equity is €50.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synektik (FRA:A2P) Overvalued in 2026?

Based on GuruFocus' analysis, Synektik stock appears to be overvalued. The current stock price of €79.00 is trading 16.2% above its estimated GF Value™ of €67.97. GuruFocus considers Synektik to be Modestly Overvalued.

Key valuation signals for FRA:A2P:

  • Total Stockholders Equity: €50.7 Mil
  • GF Value™: €67.97 vs. price of €79.00 (16.2% above fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the FRA:A2P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synektik Business Description

Other Exchanges SNT:Poland
Address Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
68GF Score

Get the complete analysis for FRA:A2P

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€79.00
Price
€67.97
GF Value